Back to Infectious Disease
Infectious Diseasev2020Evidence-Based

For Patients: VACO Index COVID-19 Mortality Risk

Estimates 30-day mortality risk after COVID-19 infection using pre-existing health conditions and demographics. Developed by researchers from Yale University and VA Connecticut Healthcare System in collaboration with the US Department of Health and Human Services.

Clinical Input Parameters

years
Range: 20 — 115 years
Clinical Assessment
Awaiting Parameters
mortality risk
—percentage
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The For Patients: VACO Index COVID-19 Mortality Risk is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within infectious disease.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

Uses age-specific coefficients, sex coefficients, and Charlson Comorbidity Index points with interaction terms. Final risk = exp(coefficient_sum) / (1 + exp(coefficient_sum))

Clinical Pearls & Practice Notes

  • This calculator estimates mortality risk based on pre-existing health conditions and does not predict risk of contracting COVID-19
  • Risk estimates are based on data from veterans and may not be fully generalizable to all populations
  • Mortality risk is 8-12 times higher than seasonal influenza mortality
  • Does not measure potential long-term health effects from COVID-19 infection
  • Results should be interpreted in consultation with healthcare professionals
  • Developed for patient-facing use to help individuals understand their risk profile

Evidence & Literature Citations

  1. Justice AC, Freiburg MS, Lopez-Class M, et al. Patient-facing COVID-19 risk tool. Developed in collaboration with US Department of Health and Human Services. Yale University and VA Connecticut Healthcare System; 2020.
  2. King JT Jr, Yoon JS, Rentsch CT, et al. Development and validation of a 30-day mortality index based on pre-existing medical administrative data from 13,323 COVID-19 patients: The Veterans Health Administration COVID-19 (VACO) Index. PLoS One. 2020;15(11):e0241825.
  3. Rentsch CT, Kidwai-Khan F, Tate JP, et al. Patterns of COVID-19 testing and mortality by race and ethnicity among United States veterans: A nationwide cohort study. PLoS Med. 2020;17(9):e1003379.

Score Interpretation Ranges

Lower Risk0 – 8.7 pts

Lower risk of 30-day mortality

Moderate Risk8.8 – 16 pts

Moderate risk of 30-day mortality

High Risk16.1 – 21.2 pts

High risk of 30-day mortality

Extreme Risk21.3 – 100 pts

Extreme risk of 30-day mortality

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.